Licensing IVD kits in India for import and manufacturing
IVD kits in India follow risk-based licensing routes. Check CDSCO import forms, manufacturing authorities, new-IVD permission and the Class A exemption.
IVD kits and reagents are in vitro diagnostic products. In India, their import, manufacture, sale and distribution are regulated under the Drugs and Cosmetics framework and the Medical Devices Rules, 2017. The route depends on intended use, risk class and whether you import or manufacture. Under ordinary licensing, State Licensing Authorities handle Class A and Class B manufacture. CDSCO's Central Licensing Authority handles Class C and Class D manufacture, and imports. Check the narrow Class A exemption before you choose that route. See CDSCO's IVD overview and its Medical Devices Rules repository.
A classification-list entry, a sale-premises registration and an import licence answer different questions. Don't treat those records as interchangeable.
Classify IVD kits by intended use
CDSCO groups IVD products into four risk classes. Class A is low risk, Class B is low-moderate risk, Class C is moderate-high risk and Class D is high risk. Classification follows intended use and the parameters in First Schedule, Part II. The words "kit", "reagent" or "PCR" do not set the class on their own. Compare the exact product and its intended use with CDSCO's classification resources.
CDSCO lists HIV test reagents/kits for detecting HIV in blood or body fluids as Class D. It lists HIV viral-load reagents/kits for estimating viral load as Class C. But those are two intended uses, not a general rule for every HIV-related product. Check the official risk-classified IVD list against your own claims.
Check IVD instruments separately against CDSCO's classification resources, and do not copy the kit's class onto every item supplied with it.
Choose the import or manufacturing route
The first three rows are the ordinary licensing routes, and only where the Class A exemption does not take that product out of the licensing regime. The last row adds MD-29 permission on top of the applicable commercial licence. CDSCO sets out these authorities and form pairs on its IVD page.
| Activity | Authority | Application and outcome |
|---|---|---|
| Manufacture Class A/B for sale or distribution, where ordinary licensing applies | State Licensing Authority | Check the applicable State manufacturing procedure |
| Manufacture Class C/D for sale or distribution | Central Licensing Authority | MD-7 application. MD-9 manufacturing licence |
| Import commercially, where ordinary licensing applies | Central Licensing Authority | MD-14 application. MD-15 import licence |
| Import or manufacture a new IVD | Central Licensing Authority | MD-28 application. MD-29 permission, in addition to the commercial licence |
A classification listing does not replace your manufacturing or import licence. Keep classification, new-IVD permission and the commercial licence separate when you prepare the application.
Importing IVD kits and reagents
For a commercial import on the ordinary route, the applicant is an Indian authorised agent. The overseas manufacturer appoints that agent through a power of attorney. Do not plan on the overseas manufacturer applying directly. See CDSCO's medical-device FAQ. The agent submits MD-14 to the Central Licensing Authority. The import licence is MD-15. See CDSCO's IVD licensing information.
Check eligibility before you build the dossier. Under rule 34, the MD-14 applicant is an authorised agent that already holds a licence to manufacture for sale or distribution, or a wholesale licence for sale or distribution. CDSCO's 2024 FAQ also lists an MD-42 sale or distribution registration certificate among the eligibility options. MD-42 is not the product's MD-15 import licence. The Rules and the FAQ cover those different functions.
Use the current MD-14 checklist on CDSCO's IVD page. Examples of Fourth Schedule evidence include:
- Labels, package inserts, and applicable manuals.
- An analytical-performance summary, including sensitivity and specificity.
- A site or plant master file.
- An essential-principles checklist.
These are examples, not a complete dossier, and not an identical list for every route. Match the submission to the applicable checklist and the Fourth Schedule.
IVD manufacturing in India
For local IVD manufacturing, set the class before you pick the authority in the table. CDSCO's IVD overview sets out the State Class A/B and Central Class C/D split.
For a Class A product, check the exemption separately. CDSCO lists G.S.R. 777(E), dated 14 October 2022, as exempting nonsterile and nonmeasuring Class A medical devices from the licensing regime. The listing does not cover every Class A device or every IVD kit. Exemption from ordinary licensing does not remove registration or other duties. Read the current text in the Rules repository before you decide how to proceed.
Check whether new-IVD permission is needed
A new brand or a new importer does not, by itself, make a product a new IVD. The Rules define a new IVD as a device the Central Licensing Authority has not approved for manufacture for sale or for import, and that is being tested to establish performance for the relevant analyte or parameter, including the technology and procedure. Assess that definition against the product in the Rules.
Where that definition applies, prior MD-29 permission is required before the manufacturing licence or the import licence can be granted. The application is MD-28. Clinical performance evaluation is a separate process. Its application is MD-24. That is not the commercial licensing route. See CDSCO's forms and checklists.
Prepare the application against current resources
Use this preparation sequence. It isn't a complete statutory checklist:
- Record the intended use and compare it with the official classification resources.
- Check whether the narrow Class A exemption applies.
- Identify the applicant and the licensing authority.
- Work through the applicable official checklist, and assess new-IVD permission separately.
On its IVD page, CDSCO says the MD-14, MD-7 and MD-28 applications are made in the sugam online portal. Also use that IVD page and the current online system. Don't assume one portal screen covers every current step.
The IVD page lists draft import guidance dated 30 January 2026, released on the site on 2 February 2026, and draft manufacturer guidance released on 9 October 2026. Both notes are still drafts. They are not a final rule amendment.
Read RegAffairs AI's answer on licensing IVD kits in India for the cited Q&A behind this guide. Check the current CDSCO text before filing, especially where the Class A exemption or new-IVD permission may apply.